welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
-
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysisObjective The benefits of pancreatic ...
-
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsMalignant transformation of adenomas of ...
-
Colectomyhttp://www.mayoclinic.org/~/media/kcms/g...
-
Familial Adenomatous Polyposis. Laparoscopic Total Proctocolectomy with J-Pouch Ileoanal Anastomosishttps://www.youtube.com/watch?v=4l1qS1wa...
-
Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisRATIONALE: Exisulind may be effectiv...
-
Long Term Treatment with Sulindac in Familial Adenomatous Polyposis: Is there an Actual Efficiacy in Prevention of ...BACKGROUND AND OBJECTIVES : Ileorectal a...
-
Familial adenomatous polyposis monitoring, Whipple procedure gave my husband more timeWhen he was 15, my husband Jesse underwe...